582
Participants
Start Date
March 19, 2025
Primary Completion Date
November 1, 2028
Study Completion Date
January 31, 2032
Trastuzumab Deruxtecan
T-DXd will be administered at a dose of 5.4 mg/kg intravenously (IV) every 3 weeks (Q3W)
Bevacizumab
Bevacizumab will be administered at a dose of 15/mg/kg IV Q3W
RECRUITING
Icahn School of Medicine at Mount Sinai, New York
RECRUITING
Greater Baltimore Medical Center, Towson
RECRUITING
UNC Hospital, Chapel Hill
RECRUITING
Broward Health Medical Center, Fort Lauderdale
RECRUITING
Miami Valley Hospital South, Centerville
RECRUITING
Indiana University, Indianapolis
RECRUITING
Avera Medical Group Gynecologic, Sioux Falls
RECRUITING
Trials365 LLC, Shreveport
RECRUITING
Fudan University Shanghai Cancer Center, Shanghai Shi
RECRUITING
Dana-Farber Cancer Institute, Boston
RECRUITING
Valley Health System, Paramus
RECRUITING
UZ Leuven, Leuven
RECRUITING
Fundação Doutor Amaral Carvalho, Jaú
RECRUITING
Liga Norte-Rio-Grandense Contra o Cancer, Natal
RECRUITING
Centro Gaucho Integrado de Oncologia, Hematologia, Ensino e Pesquisa Hospital Mae de Deus, Porto Alegre
RECRUITING
BP A Beneficencia Portuguesa de Sao Paulo, São Paulo
RECRUITING
Beijing Cancer Hospital, Beijing
RECRUITING
The First Hospital of Jilin University, Changchun
RECRUITING
Chongqing Cancer Hospital, Chongqing
RECRUITING
The Second Hospital of Dalian Medical University, Dalian
RECRUITING
Sun Yat-Sen University Cancer Center, Guangzhou
RECRUITING
Hainan General Hospital, Haikou
RECRUITING
Zhejiang Cancer Hospital, Hangzhou
RECRUITING
Women's Hospital School of Medicine Zhejiang University, Hangzhoushi
RECRUITING
Shandong Cancer Hospital, Jinan
RECRUITING
Jiangxi Maternal and Child Health Hospital, Nanchang
RECRUITING
Zhong Da Hospital, Southeast University, Nanjing
RECRUITING
Guangxi Medical University Cancer Hopstial, Nanning
RECRUITING
Affiliated Hospital (Suzhou First People's Hospital), Suzhou
RECRUITING
Tianjin Medical University Cancer Institute & Hospital, Tianjin
RECRUITING
Tongji Hospital Tongji Medical College of HUST, Wuhan
RECRUITING
The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an
RECRUITING
The Lady Davis Carmel Medical Center, Haifa
RECRUITING
Kurume University Hospital, Kurume-shi
RECRUITING
Aichi Cancer Center Hospital, Nagoya
RECRUITING
Niigata Cancer Center Hospital, Niigata
RECRUITING
Kindai University Hospital, Osakasayama-shi
RECRUITING
Shizuoka Cancer Center, Sunto-gun
RECRUITING
Keimyung University Dongsan Hospital, Daegu
RECRUITING
Asan Medical Center, Seoul
RECRUITING
Seoul National University Hospital, Seoul
RECRUITING
Severance Hospital, Yonsei University Health System, Seoul
RECRUITING
Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City
RECRUITING
Chang Gung Memorial Hospital, Linkou Taoyuan
RECRUITING
Taichung Veterans General Hospital, Taichung
RECRUITING
National Cheng Kung University Hospital, Tainan City
RECRUITING
MacKay Memorial Hospital- Taipei Branch, Taipei
RECRUITING
National Taiwan University Hospital, Taipei
RECRUITING
Taipei Veterans General Hospital, Taipei
RECRUITING
Hyogo Cancer Center, Akashi
RECRUITING
National Cancer Center Hospital, Chūōku
RECRUITING
Fukushima Medical University Hospital, Fukushima
RECRUITING
Saitama Medical University International Medical Center, Hidaka-Shi
RECRUITING
Cancer Institute Hospital of JFCR, Kōtoku
RECRUITING
Okayama University Hosptial, Okayama
RECRUITING
NHO Hokkaido Cancer Center, Sapporo
RECRUITING
Iwate Medical University Hospital, Shiwa-Gun
RECRUITING
Mie University Hospital, Tsu
RECRUITING
Yamagata University Hospital, Yamagata
Lead Sponsor
Daiichi Sankyo
INDUSTRY